A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid

@inproceedings{Herskovits2013ALA,
  title={A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid},
  author={Adrianna Z. Herskovits and Joseph J Locascio and E. R. Peskind and Ge Li and Bradley T. Hyman},
  booktitle={PloS one},
  year={2013}
}
Amyloid beta (aβ) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble aβ oligomers are a critical pathologic species. Diagnostic evaluations rely on the measurement of increased tau and decreased aβ42 in the cerebrospinal fluid (CSF) from AD patients and evidence for oligomeric aβ in patient CSF is conflicting. In this study, we have adapted a monoclonal single antibody sandwich ELISA assay to a… CONTINUE READING
Highly Cited
This paper has 174 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
24 Citations
48 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

175 Citations

05010020142015201620172018
Citations per Year
Semantic Scholar estimates that this publication has 175 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Comparison of Two Analytical Platforms for the Clinical Qualification of Alzheimer’s Disease Biomarkers in PathologicallyConfirmed Dementia

  • N Le Bastard, E Coart, H Vanderstichele, E Vanmechelen, JJ Martin
  • J Alzheimers Dis
  • 2013

Similar Papers

Loading similar papers…